Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3394485
Max Phase: Preclinical
Molecular Formula: C18H20N6
Molecular Weight: 320.40
Molecule Type: Small molecule
Associated Items:
ID: ALA3394485
Max Phase: Preclinical
Molecular Formula: C18H20N6
Molecular Weight: 320.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc(NCCN(C)C)n2nc3nc4ccccc4cc3c2n1
Standard InChI: InChI=1S/C18H20N6/c1-12-10-16(19-8-9-23(2)3)24-18(20-12)14-11-13-6-4-5-7-15(13)21-17(14)22-24/h4-7,10-11,19H,8-9H2,1-3H3
Standard InChI Key: JTMJQHNZSLMVKW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 320.40 | Molecular Weight (Monoisotopic): 320.1749 | AlogP: 2.71 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.35 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.88 | CX LogP: 2.22 | CX LogD: 0.74 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.63 | Np Likeness Score: -1.73 |
1. Karthikeyan C, Lee C, Moore J, Mittal R, Suswam EA, Abbott KL, Pondugula SR, Manne U, Narayanan NK, Trivedi P, Tiwari AK, Tiwari AK.. (2015) IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells., 23 (3): [PMID:25537531] [10.1016/j.bmc.2014.11.043] |
Source(1):